Cinpanemab in Early Parkinson Disease: Evaluation of Biomarker Results From the Phase 2 SPARK Clinical Trial von Hutchison, R Matthew, Fraser, Kyle, Yang, Minhua, Fox, Tara, Hirschhorn, Elizabeth, Njingti, Edwin, Scott, David, Bedell, Barry J, Kistner, Kristi M, Cedarbaum, Jesse M, Evans, Karleyton C, Graham, Danielle, Martarello, Laurent, Mollenhauer, Brit, Lang, Anthony E, Dam, Tien, Beaver, John

Volltext